Our results address the role of TUBB4A in prostate cancer progression and provide a therapeutic target for patients who have tumors with TUBB4A overexpression, leading to the development of new targeted therapies of aggressive prostate cancer. The gene discussed is TUBB4A; the disease is Familial prostate cancer.